Pioneering Natural Weight-Loss Treatment

QLC’s client set out to address a significant gap in the weight-loss treatment market. Existing products offered limited effectiveness, while surgical interventions, though impactful, were invasive, costly and inaccessible for many patients.

The client aimed to develop an affordable, natural weight-loss tablet that could safely modulate appetite by triggering the secretion of appetite-suppressing hormones in the large bowel.

Achieving this goal required overcoming scientific uncertainties and conducting extensive research and development.

The approach

The client embarked on a comprehensive R&D journey to develop a treatment that was both effective and safe. Key stages of the project included:

Early research:

• Using tissue assay platforms to evaluate combinations of natural substances.
• Identifying formulations that could modulate hormone secretion effectively.

Formulation development:

• Experimenting with the transition of the formulation from a paste to a powder to improve its usability and scalability.
• Ensuring that the change in form did not compromise the treatment’s performance.

Clinical trials:

• Conducting trials to test the formulation's effectiveness in appetite suppression.
• Exploring the impact of varying doses on hormone secretion to determine optimal dosages.

By the end of the last claim period, the treatment was in its final stages of development. The client had successfully navigated key technical challenges, including identifying an effective natural formulation and optimising its delivery format. This innovative approach has the potential to transform weight-loss treatment, providing a safe and accessible alternative to surgical interventions.